AIM ImmunoTech Inc (AIM)
0.781
0.00 (0.00%)
USD |
NYAM |
Jul 01, 16:00
0.7805
0.00 (0.00%)
After-Hours: 20:00
AIM ImmunoTech Revenue (TTM): 0.139M for March 31, 2022
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| March 31, 2022 | 0.139M |
| December 31, 2021 | 0.134M |
| September 30, 2021 | 0.126M |
| June 30, 2021 | 0.129M |
| March 31, 2021 | 0.146M |
| December 31, 2020 | 0.163M |
| September 30, 2020 | 0.171M |
| June 30, 2020 | 0.196M |
| March 31, 2020 | 0.185M |
| December 31, 2019 | |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | 0.367M |
| September 30, 2018 | 0.177M |
| June 30, 2018 | 0.229M |
| March 31, 2018 | 0.409M |
| December 31, 2017 | 0.437M |
| September 30, 2017 | 0.403M |
| June 30, 2017 | 0.335M |
| March 31, 2017 | 0.137M |
| December 31, 2016 | 0.092M |
| September 30, 2016 | 0.103M |
| June 30, 2016 | 0.104M |
| March 31, 2016 | 0.136M |
| Date | Value |
|---|---|
| December 31, 2015 | 0.133M |
| September 30, 2015 | 0.146M |
| June 30, 2015 | 0.168M |
| March 31, 2015 | 0.157M |
| December 31, 2014 | 0.197M |
| September 30, 2014 | 0.193M |
| June 30, 2014 | 0.184M |
| March 31, 2014 | 0.184M |
| December 31, 2013 | 0.15M |
| September 30, 2013 | 0.167M |
| June 30, 2013 | 0.17M |
| March 31, 2013 | 0.183M |
| December 31, 2012 | 0.213M |
| September 30, 2012 | 0.198M |
| June 30, 2012 | 0.204M |
| March 31, 2012 | 0.191M |
| December 31, 2011 | 0.161M |
| September 30, 2011 | 0.15M |
| June 30, 2011 | 0.14M |
| March 31, 2011 | 0.145M |
| December 31, 2010 | 0.135M |
| September 30, 2010 | 0.148M |
| June 30, 2010 | 0.138M |
| March 31, 2010 | 0.114M |
| December 31, 2009 | 0.111M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
0.126M
Minimum
Sep 2021
0.437M
Maximum
Dec 2017
0.2274M
Average
0.177M
Median
Sep 2018
Revenue (TTM) Benchmarks
| Protalix BioTherapeutics Inc | 43.12M |
| Armata Pharmaceuticals Inc | -- |
| Agenus Inc | 309.89M |
| BioCryst Pharmaceuticals Inc | 188.03M |
| Curis Inc | 10.52M |